The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Pneumonia Nosode 4016
Pneumonia Nosode · HUMAN ADENOVIRUS B SEROTYPE 3 30 [hp_X]/59mL; CHLAMYDIA TRACHOMATIS 30 [hp_X]/59mL; CHLAMYDOPHILA PSITTACI 30 [hp_X]/59mL; COCCIDIOIDES IMMITIS WHOLE 30 [hp_X]/59mL; COXSACKIEVIRUS A21 30 [hp_X]/59mL; HAEMOPHILUS INFLUENZAE 30 [hp_X]/59mL; STREPTOCOCCUS VIRIDANS GROUP 30 [hp_X]/59mL; HISTOPLASMA CAPSULATUM 30 [hp_X]/59mL; INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL; KLEBSIELLA PNEUMONIAE 30 [hp_X]/59mL; MYCOBACTERIUM TUBERCULOSIS 30 [hp_X]/59mL; MYCOPLASMA PNEUMONIAE 30 [hp_X]/59mL; STREPTOCOCCUS PYOGENES 30 [hp_X]/59mL; HUMAN RESPIRATORY SYNCYTIAL VIRUS 30 [hp_X]/59mL; COXIELLA BURNETII 30 [hp_X]/59mL; RICKETTSIA RICKETTSII 30 [hp_X]/59mL; STAPHYLOCOCCUS AUREUS 30 [hp_X]/59mL · Liquid · Oral · Professional Complementary Health Formulas
NDC 63083-4016-02 · 59 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Pneumonia Nosode (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Professional Complementary Health Formulas | HUMAN ADENOVIRUS B SEROTYPE 3 30 [hp_X]/59mL; CHLAMYDIA TRACHOMATIS 30 [hp_X]/59mL; CHLAMYDOPHILA PSITTACI 30 [hp_X]/59mL; COCCIDIOIDES IMMITIS WHOLE 30 [hp_X]/59mL; COXSACKIEVIRUS A21 30 [hp_X]/59mL; HAEMOPHILUS INFLUENZAE 30 [hp_X]/59mL; STREPTOCOCCUS VIRIDANS GROUP 30 [hp_X]/59mL; HISTOPLASMA CAPSULATUM 30 [hp_X]/59mL; INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL; KLEBSIELLA PNEUMONIAE 30 [hp_X]/59mL; MYCOBACTERIUM TUBERCULOSIS 30 [hp_X]/59mL; MYCOPLASMA PNEUMONIAE 30 [hp_X]/59mL; STREPTOCOCCUS PYOGENES 30 [hp_X]/59mL; HUMAN RESPIRATORY SYNCYTIAL VIRUS 30 [hp_X]/59mL; COXIELLA BURNETII 30 [hp_X]/59mL; RICKETTSIA RICKETTSII 30 [hp_X]/59mL; STAPHYLOCOCCUS AUREUS 30 [hp_X]/59mL | Jul 22, 2026 | Sep 2, 2026 |
| Professional Complementary Health Formulas | CHLAMYDIA TRACHOMATIS 30 [hp_X]/59mL; CHLAMYDOPHILA PSITTACI 30 [hp_X]/59mL; COCCIDIOIDES IMMITIS WHOLE 30 [hp_X]/59mL; COXIELLA BURNETII 30 [hp_X]/59mL; COXSACKIEVIRUS A21 30 [hp_X]/59mL; HAEMOPHILUS INFLUENZAE 30 [hp_X]/59mL; HISTOPLASMA CAPSULATUM 30 [hp_X]/59mL; HUMAN ADENOVIRUS B SEROTYPE 3 30 [hp_X]/59mL; HUMAN RESPIRATORY SYNCYTIAL VIRUS 30 [hp_X]/59mL; INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL; KLEBSIELLA PNEUMONIAE 30 [hp_X]/59mL; MYCOBACTERIUM TUBERCULOSIS 30 [hp_X]/59mL; MYCOPLASMA PNEUMONIAE 30 [hp_X]/59mL; RICKETTSIA RICKETTSII 30 [hp_X]/59mL; STAPHYLOCOCCUS AUREUS 30 [hp_X]/59mL; STREPTOCOCCUS PYOGENES 30 [hp_X]/59mL; STREPTOCOCCUS VIRIDANS GROUP 30 [hp_X]/59mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Pneumonia Nosode 4016 — NDC 63083-4016-02," retrieved September 3, 2026, https://drugdashboards.com/drug/63083401602.
Free to cite with attribution — see how the data is put together.